Hakutulokset - Andreas Pinter

Criteria for Dose Adjustment of Tildrakizumab in Psoriasis Vulgaris Tekijä Andreas Pinter, Diamant Thaçi, Michael Sebastian

Hae kokoteksti

Best Responders and Super-Responders to Calcipotriol and Betamethasone Dipropionate PAD-Cream: A Post Hoc Pooled Analysis of Two Phase 3 Trials Tekijä Andreas Pinter, Jordi Galván, Frank Freischläger

Hae kokoteksti

Efficacy and Safety of Topical Tacrolimus Microemulsion Applied Twice Daily in Patients with Mild to Moderate Scalp Psoriasis Tekijä Andreas Pinter, Athanasios Tsianakas, Adina Eichner, for the ScaTAC study group

Hae kokoteksti

Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey Tekijä Andreas Pinter, Nicole Mielke, Bartosz Malisiewicz, Roland Kaufmann, Anke König

Hae kokoteksti

Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin Accord... Tekijä Michael J. Cork, Benjamin Lockshin, Andreas Pinter, Zhen Chen, Brad Shumel, Randy Prescilla

Hae kokoteksti

Patient and Clinician‐Reported Outcomes and Adherence to Calcipotriene/Betamethasone Dipropionate PAD‐Cream in Treatment of Scalp Psoriasis in Adults: An Interim Analysis of the PR... Tekijä Andreas Pinter, Jose Luis López Estebaranz, Anthony Bewley, Jordi Galván, Siva Narayanan, Volker Koscielny, Ismail Kasujee

Hae kokoteksti

Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study Tekijä Andreas Pinter, Ahmed M. Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Bang Truong, Luis Puig, Mark Lebwohl

Hae kokoteksti

Influenza Vaccination in Psoriatic Patients—Epidemiology and Patient Perceptions: A German Multicenter Study (Vac-Pso) Tekijä Christian Kromer, Phoebe Wellmann, Ralf Siemer, Selina Klein, Johannes Mohr, Andreas Pinter, Dagmar Wilsmann-Theis, Rotraut Mössner

Hae kokoteksti

Treatment switching and associated economic outcomes in patients with plaque psoriasis treated with biologics: A retrospective analysis of German claims data 2016−2021 Tekijä Andreas Pinter, Ahmed M. Soliman, Karina C. Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G. Lebwohl

Hae kokoteksti

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A S... Tekijä Linda Stein Gold, Andreas Pinter, April Armstrong, Matthias Augustin, Petr Arenberger, Neil Bhatia, Morten Praestegaard, Lars Iversen, Adam Reich

Hae kokoteksti

Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso Tekijä Phoebe Wellmann, Christian Kromer, Ralf Siemer, Selina Klein, Johannes Mohr, Undine Lippert, Andreas Pinter, Dagmar Wilsmann-Theis, Rotraut Mössner

Hae kokoteksti

Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan Tekijä Yayoi Tada, Ahmed M. Soliman, Kanako Ishii, Ryuta Sakuma, Luis Puig, Matthew Davis, Dominic Nunag, Andreas Pinter, Shinichi Imafuku

Hae kokoteksti

Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data Tekijä Andreas Pinter, Ahmed M. Soliman, Karina C. Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G. Lebwohl

Hae kokoteksti

Bimekizumab efficacy in scalp, nail and palmoplantar psoriasis versus comparators and over 4 years Tekijä Paolo Gisondi, Boni Elewski, Andreas Pinter, Yukie Yamaguchi, Melinda Gooderham, Sarah Kavanagh, Krista Wixted, Nancy Cross, Balint Szilagyi, Joseph F. Merola

Hae kokoteksti

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review Tekijä Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter

Hae kokoteksti

Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of hea... Tekijä Andreas Pinter, Kilian Eyerich, Antonio Costanzo, Alyssa Garrelts, Christopher Schuster, Can Mert, Anastasia Lampropoulou, Konstantinos Fotiou, Julia-Tatjana Maul, Kim A. Papp

Hae kokoteksti

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants... Tekijä Kristian Reich, Kilian Eyerich, Knut Schäkel, Peter Weisenseel, Andreas Pinter, Khusru Asadullah, Sven Wegner, Ernesto J Muñoz-Elias, Holger Bartz, Friedmann J H Taut

Hae kokoteksti

Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis Tekijä Matthias Augustin, Alice B. Gottlieb, Mark Lebwohl, Andreas Pinter, Richard B. Warren, Luis Puig, Rhys Warham, Jérémy Lambert, Susanne Wiegratz, Balint Szilagyi, Andrew Blauvelt

Hae kokoteksti

Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with B... Tekijä Elisabeth Riedl, Andreas Pinter, Shirin Zaheri, Antonio Costanzo, Alan Brnabic, Bruce Konicek, Robert McKenzie, Anastasia Lampropoulou, Mohamed El Rayes, Natalie Haustrup, Christopher Schuster

Hae kokoteksti

Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis: Results from the International, Observational Psoriasis Stud... Tekijä Andreas Pinter, Alan Brnabic, Emanuele Trovato, Lluís Puig, Jose-Manuel Carrascosa, Thierry Boyé, Matteo Megna, Silvia Sabatino, Inmaculada De La Torre, Julia-Tatjana Maul

Hae kokoteksti